Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence of Extended Spectrum β-lactamase-Producing Klebsiella pneumoniae in Clinical Isolates

Khalid Abdalla Ali Abdel Rahim 1 , 2 , * and Ahmed Mohamed Ali Mohamed 3
Authors Information
1 Botany and Microbiology Department, College of Science, King Saud University, Saudi Arabi
2 Botany Department, Faculty of Science, Sohag University, Sohag, Egypt
3 Department of Microbiology, College of Health Science, University of Dammam, Hafr Al Batin, Saudi Arabia
Article information
  • Jundishapur Journal of Microbiology: November 01, 2014, 7 (11); e17114
  • Published Online: November 1, 2014
  • Article Type: Research Article
  • Received: February 16, 2014
  • Revised: March 2, 2014
  • Accepted: April 14, 2014
  • DOI: 10.5812/jjm.17114

To Cite: Ali Abdel Rahim K A, Mohamed Ali Mohamed A. Prevalence of Extended Spectrum β-lactamase-Producing Klebsiella pneumoniae in Clinical Isolates, Jundishapur J Microbiol. 2014 ; 7(11):e17114. doi: 10.5812/jjm.17114.

Abstract
Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Palucha A, Mikiewicz B, Hryniewicz W, Gniadkowski M. Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J Antimicrob Chemother. 1999; 44(4): 489-99[PubMed]
  • 2. Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol. 2001; 39(6): 2206-12[DOI][PubMed]
  • 3. Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection. 1989; 17(5): 316-21[PubMed]
  • 4. DeSirot D, Champs C, Chanal C, Labia F, Darfeuille-Michaud A. Translocation of antibiotics resistance determinants including extended spectrum -lactamase between conjugative plasmids of Klebsiella pneumonia and Escherichia coli. Antimicrob Agents and Chemother. 1989; 34(1): 1576-81
  • 5. Selden R, Lee S, Wang WL, Bennett JV, Eickhoff TC. Nosocomial klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med. 1971; 74(5): 657-64[PubMed]
  • 6. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001; 14(4): 933-51[DOI][PubMed]
  • 7. Rice LB, Bonomo RA. beta -Lactamases: which ones are clinically important? Drug Resist Updat. 2000; 3(3): 178-89[DOI][PubMed]
  • 8. Moland ES, Black JA, Ourada J, Reisbig MD, Hanson ND, Thomson KS. Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob Agents Chemother. 2002; 46(12): 3837-42[PubMed]
  • 9. Sturenburg E, Mack D. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect. 2003; 47(4): 273-95[PubMed]
  • 10. Clinical and Laboratory Standards Institute . Informational Supplement,. 2006;
  • 11. MacKenzie FM, Miller CA, Gould IM. Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection. Clin Microbiol Infect. 2002; 8(11): 715-24[PubMed]
  • 12. Hansotia JB, Agarwal V, Pathak AA, Saoji AM. Extended spectrum beta-lactamase mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Indian J Med Res. 1997; 105: 158-61[PubMed]
  • 13. Lal P, Kapil A, Das BK, Sood S. Occurrence of TEM & SHV gene in extended spectrum beta-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J Med Res. 2007; 125(2): 173-8[PubMed]
  • 14. Rodrigues C, Joshi P, Jani SH, Alphonse M, Radhakrishnan R, Mehta A. Detection of -lactamases in nosocomial gram negative clinical isolates. Indian J Med Microbiol. 2004; 22(4): 247-50[PubMed]
  • 15. Ananthan S, Subha A. Cefoxitin resistance mediated by loss of a porin in clinical strains of Klebsiella pneumoniae and Escherichia coli. Indian J Med Microbiol. 2005; 23(1): 20-3[PubMed]
  • 16. Emery CL, Weymouth LA. Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center. J Clin Microbiol. 1997; 35(8): 2061-7[PubMed]
  • 17. Shannon K, Stapleton P, Xiang X, Johnson A, Beattie H, El Bakri F, et al. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol. 1998; 36(10): 3105-10[PubMed]
  • 18. Gupta V, Singla N, Chander J. Detection of ESBLs using third & fourth generation cephalosporins in double disc synergy test. Indian J Med Res. 2007; 126(5): 486-7[PubMed]
  • 19. Saurina G, Quale JM, Manikal VM, Oydna E, Landman D. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother. 2000; 45(6): 895-8[PubMed]
  • 20. Romero ED, Padilla TP, Hernandez AH, Grande RP, Vazquez MF, Garcia IG, et al. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases. Diagn Microbiol Infect Dis. 2007; 59(4): 433-7[DOI][PubMed]
  • 21. Kuo KC, Shen YH, Hwang KP. Clinical implications and risk factors of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection in children: a case-control retrospective study in a medical center in southern Taiwan. J Microbiol Immunol Infect. 2007; 40(3): 248-54[PubMed]
  • 22. Hosoglu S, Gundes S, Kolayli F, Karadenizli A, Demirdag K, Gunaydin M, et al. Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals. Indian J Med Microbiol. 2007; 25(4): 346-50[PubMed]
  • 23. Messai Y, Iabadene H, Benhassine T, Alouache S, Tazir M, Gautier V, et al. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Pathol Biol (Paris). 2008; 56(5): 319-25[DOI][PubMed]
  • 24. Xiong Z, Zhu D, Zhang Y, Wang F. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates]. Zhonghua Yi Xue Za Zhi. 2002; 82(21): 1476-9[PubMed]
  • 25. Goossens H, Mystic Study Group . MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis. 2001; 41(4): 183-9[PubMed]
  • 26. Duttaroy B, Mehta S. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli. Indian J Pathol Microbiol. 2005; 48(1): 45-8[PubMed]
  • 27. Babypadmini S, Appalaraju B. Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol. 2004; 22(3): 172-4[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments